ABOUT
Unlocking the therapeutic potential of mimicry
Mimicry is one of nature’s oldest tricks in which organisms gain adaptive advantages by imitating others.
We adapted this idea to drug discovery. MIMIC™, our computationally driven bioplatform that couples machine learning with molecular mimicry, engineers therapeutics to trigger a desired biological response.
Our MIMIC platform opens the possibility to develop engineered medicines with specific features to access a range of targets, including those that were previously intractable.
Founded by Flagship Pioneering in 2021, Metaphore aims to unlock breakthroughs that outperform today’s drugs for maximum patient impact.
Daniel Acker, PhD
Co-Founder and CIO, Metaphore
Principal, Flagship Pioneering
Lovisa Afzelius, PhD, MBA
Co-Founder and CEO, Metaphore
General Partner, Flagship Pioneering
Chaz Hinzman, PhD
Head of Strategy and Operations, Metaphore
Principal, Flagship Pioneering
Kristen Hopson, PhD
Senior Vice President of Translational Sciences, Metaphore
Oz Malkesman, PhD, MBA
Vice President, Head of Program Management, Metaphore
Marcin Paduch, PhD
Vice President, Platform Discovery, Metaphore
